Pharma CEO pay

Latest Headlines

Latest Headlines

Elan execs get $8M in stock awards

Elan's top executives got some good news recently: They've been awarded hundreds of thousands of stock options worth 6 million euros, or $8.16 million. The catch: They're spread out over the next

Is Novartis paying Vasella too much?

Former Novartis CEO Dan Vasella's 2009 bonus will be close to three times the amount he would be due based on relative earnings growth among large-cap peers, according to a new corporate-governance

Biogen shareholder denounces CEO pay

A Biogen Idec shareholder is castigating CEO James Mullen (photo) for selling $85 million in company stock and picking up $63 million in compensation, Reuters reports. And no, the shareholder isn't

Is bad-news Genzyme paying CEO too much?

When a company hits the skids, fingers start to point. And lately, fingers have been pointing pretty forcefully at Henri Termeer (photo), CEO of the ill-fated company Genzyme. Naturally, inquiring

Big Pharma execs top highest-paid Swiss list

Who tops the list of highest-paid Swiss executives? None other than pharma's own Daniel Vasella (photo), CEO of Novartis. Vasella's 2008 compensation grew by more than 20 percent from 2007, to 20.5

Merck chief's pension mushrooms by $10M

Merck CEO Dick Clark saw his pension benefit rise by nearly $10 million to $21.7 million in 2008, the Wall Street Journal reports in a survey of companies whose stock prices fell but executive

Disgraced ex-Astra CEO must forfeit pay

The financial industry may not be clawing back salary and bonuses from the bankers whose wild behavior cost their companies money. But you can't say the same about Big Pharma. Lars Bildman (

Schering execs in line for $107M-plus

Just how much do Schering-Plough execs stand to gain from the $41 billion Merck merger? The final numbers are in--and very official, having been reported to the Securities & Exchange Commission

Glaxo investors bless exec-pay plans

We're all familiar with the brouhaha that occasionally attended Jean-Pierre Garnier's annual pay package. The ex-chief of GlaxoSmithKline drew shareholder ire for bonuses and stock awards they

Will GSK investors revolt over Garnier bonus?

A U.K. shareholder group is up in arms over Jean-Pierre Garnier's (photo) bonus. Sound like a broken record? Or like a news story from a time capsule circa, oh, 2003? Nope, it's today's story--and